Total N | Anti-SARS-CoV-2 negative | Anti-SARS-CoV-2 positive | P value (Fisher's test) | Raw total | P value (rank-sum test) | ||||
n | % | n | % | Median | IQR | ||||
Total | 294 | 97.03% | 9 | 2.97% | 0.12 | 0.05–0.18 | |||
Subjective assessment scale 1–6 | 277 | 272 | 98.91% | 3 | 1.09% | <0.001 | 0.12 | 0.05–0.18 | 0.0562 |
Subjective assessment scale 7–10 | 28 | 22 | 78.57% | 6 | 21.43% | 0.155 | 0.06–0.37 | ||
Respiratory symptoms 0–4 | 304 | 297 | 98.34% | 5 | 1.66% | <0.001 | 0.12 | 0.05–0.18 | 0.2246 |
Respiratory symptoms 5–6 | 13 | 9 | 69.23% | 4 | 30.77% | 0.15 | 0.05–1.90 | ||
Aches/pains 0–4 | 30 9 | 301 | 98.05% | 6 | 1.95% | 0.001 | 0.12 | 0.05–0.18 | 0.4205 |
Aches/pains 5 | 9 | 6 | 66.67% | 3 | 33.33% | 0.15 | 0.05–3.70 | ||
Abdominal symptoms 0–1 | 290 | 282 | 97.92% | 6 | 2.08% | 0.037 | 0.12 | 0.05–0.18 | 0.6149 |
Abdominal symptoms 2–3 | 28 | 25 | 89.29% | 3 | 10.71% | 0.145 | 0.05–0.21 | ||
Illness 0–2 | 300 | 294 | 98.66% | 4 | 1.34% | <0.001 | 0.12 | 0.05–0.18 | 0.2613 |
Illness3-4 | 16 | 11 | 68.75% | 5 | 31.25% | 0.14 | 0.05–6.85 |
*Semiquantitative results of ADVIA Centaur test binding to S1 RBD antigen are shown.